GENERIC 19891594

Download in:

Switch to

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006826, umls-concept:C0029456, umls-concept:C0205170, umls-concept:C1690432, umls-concept:C2347784
pubmed:issue	17
pubmed:dateCreated	2009-11-25
pubmed:abstractText	Bone loss associated with low oestrogen levels in postmenopausal women, and with androgen deprivation therapy in men with hormone-sensitive prostate cancer, result in an increased incidence of fractures. Denosumab has been shown to increase bone mineral density in these two conditions.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19891594-19671655, http://linkedlifedata.com/resource/pubmed/commentcorrection/19891594-19671656
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100897346
pubmed:status	PubMed-not-MEDLINE
pubmed:month	Dec
pubmed:issn	1744-7666
pubmed:author	pubmed-author:DoggrellSheila ASA
pubmed:issnType	Electronic
pubmed:volume	10
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2939-43
pubmed:year	2009
pubmed:articleTitle	Good clinical endpoints with denosumab in osteoporosis and cancer.
pubmed:affiliation	Queensland University of Technology, School of Life Sciences, GPO Box 2334, QLD4001, Brisbane, Australia. sheila.doggrell@qut.edu.au
pubmed:publicationType	Journal Article, Comment